Registration Rights Agreement Dated as of January 9, 2008 among OSI Pharmaceuticals, Inc. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated andRegistration Rights Agreement • January 15th, 2008 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into this 9th day of January, 2008, among OSI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and J.P. Morgan Securities Inc. (“JPMorgan”, and together with Merrill Lynch, the “Initial Purchasers”).
OSI PHARMACEUTICALS, INC., as Issuer, and THE BANK OF NEW YORK, as Trustee INDENTURE Dated as of January 9, 2008 3% Convertible Senior Subordinated Notes Due 2038Indenture • January 15th, 2008 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
THIS INDENTURE, dated as of January 9, 2008, is between OSI Pharmaceuticals, Inc., a corporation duly organized under the laws of the State of Delaware (the “Company”), and The Bank of New York, a New York banking corporation duly incorporated under the laws of the State of New York, as Trustee (the “Trustee”).
